ANI PHARMACEUTICALS INC cotiza a 73.59 USD y tiene una capitalización bursátil de $1.7B. En los últimos 12 meses ha facturado $978M con un margen de flujo de caja libre del 19.4%. Cotiza a 9.8 veces su flujo de caja libre (P/FCF) y a un PER de 15.6. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $2.21 | $2.05 | $2.33 |
| Estimado | $2.18 | $2.04 | $1.30 | $1.98 |
| Sorpresa | — | +8.3% | +57.7% | +17.7% |
| Métrica | ANIP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 61.4% | 57.0% | +4.3% |
| Operating Margin | 12.6% | -38.6% | +51.2% |
| Net Margin | 8.9% | -33.6% | +42.4% |
| FCF Margin | 19.4% | -13.9% | +33.3% |
| ROE | 14.5% | -40.4% | +54.9% |
| ROA | 5.4% | -32.0% | +37.4% |
| Current Ratio | 2.71 | 2.84 | -0.13 |
| Debt / Equity | 0.54 | 0.28 | +0.26 |